Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1202140
Max Phase: Preclinical
Molecular Formula: C36H37F3N6O14
Molecular Weight: 720.69
Molecule Type: Small molecule
Associated Items:
ID: ALA1202140
Max Phase: Preclinical
Molecular Formula: C36H37F3N6O14
Molecular Weight: 720.69
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C#CCN(Cc1ccc2ncnc(O)c2c1)c1ccc(C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)cc1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C34H36N6O12.C2HF3O2/c1-2-15-40(17-19-3-8-23-22(16-19)31(46)36-18-35-23)21-6-4-20(5-7-21)30(45)39-26(34(51)52)10-13-28(42)37-24(32(47)48)9-12-27(41)38-25(33(49)50)11-14-29(43)44;3-2(4,5)1(6)7/h1,3-8,16,18,24-26H,9-15,17H2,(H,37,42)(H,38,41)(H,39,45)(H,43,44)(H,47,48)(H,49,50)(H,51,52)(H,35,36,46);(H,6,7)/t24-,25-,26-;/m0./s1
Standard InChI Key: JREIGAFVCNMGJR-OUKLVGRUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 720.69 | Molecular Weight (Monoisotopic): 720.2391 | AlogP: 0.72 | #Rotatable Bonds: 20 |
Polar Surface Area: 285.75 | Molecular Species: ACID | HBA: 11 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.91 | CX Basic pKa: 0.84 | CX LogP: 0.77 | CX LogD: -12.43 |
Aromatic Rings: 3 | Heavy Atoms: 52 | QED Weighted: 0.07 | Np Likeness Score: -0.57 |
1. Bisset GM, Pawelczak K, Jackman AL, Calvert AH, Hughes LR.. (1992) Syntheses and thymidylate synthase inhibitory activity of the poly-gamma-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino ]-2-thenoyl]-L-glutamic acid (ICI D1694) and other quinazoline antifolates., 35 (5): [PMID:1372358] [10.1021/jm00083a008] |
Source(1):